Granted Patent B2

US 12,312,350 · App. 18/763,258 · Granted May 27, 2025

Inventor: Stéphane Dorich (Pointe-Claire, CA)

Assignee: Ventus Therapeutics U.S., Inc.

C07D471/04A61K31/501A61K31/502A61K31/5025A61K31/5377C07D405/12C07D491/048C07D495/04C07D519/00

Abstract

Claims (12)

1. A compound of formula:

or a pharmaceutically acceptable salt thereof, or a stereoisomer of any one of the foregoing.

2. A compound of formula:

or a pharmaceutically acceptable salt thereof.

3. The compound of claim 1 , wherein the compound is the stereoisomer of:

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 2 , wherein the compound is:

5. The compound of claim 2 , wherein the compound is a pharmaceutically acceptable salt of:

6. A pharmaceutical composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof, or a stereoisomer of any one of the foregoing, and one or more pharmaceutically acceptable excipients or carriers.

7. The pharmaceutical composition comprising the compound of claim 2 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients or carriers.

8. A pharmaceutical composition comprising the compound of claim 4 and one or more pharmaceutically acceptable excipients or carriers.

9. A pharmaceutical composition comprising the pharmaceutically acceptable salt of claim 5 and one or more pharmaceutically acceptable excipients or carriers.

Assignments (2)

Continuity (5)

References Cited (400)